Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study

scientific article published on 01 August 2019

Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PONE.0220641
P932PMC publication ID6675099
P698PubMed publication ID31369638

P50authorHsin-Yi YangQ92340614
P2093author name stringWan-Ting Huang
Herng-Sheng Lee
Solomon Chih-Cheng Chen
Yung-Chu Hsu
P2860cites workA link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testingQ24673627
Irritable Bowel SyndromeQ61834447
Drug-Induced Restless Legs SyndromeQ87885095
Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysisQ88673222
Restless legs symptoms in thyroid disordersQ43499950
Association between irritable bowel syndrome and colorectal cancer: a nationwide population-based studyQ43880983
Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative.Q44007067
Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants.Q44120906
Incidence of restless legs syndrome in two population-based cohort studies in GermanyQ44372039
The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain.Q45423449
Cardiovascular risk factors in restless legs syndrome.Q45969190
Gender differences in the association between antidepressant use and restless legs syndromeQ46057248
Corelease of dopamine and serotonin from striatal dopamine terminalsQ46429998
Patients with primary restless legs syndrome have higher prevalence of autonomic dysfunction and irritable bowel syndromeQ47640529
Association between irritable bowel syndrome and restless legs syndrome in the general populationQ48251452
Irritable bowel syndrome correlates with increased risk of Parkinson's disease in TaiwanQ48368095
Epidemiology of restless legs syndrome in Turkish adults on the western Black Sea coast of Turkey: A door-to-door study in a rural areaQ48402231
Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly.Q52028290
Genetics of restless legs syndromeQ57040687
Functional bowel disordersQ29620328
Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and ManagementQ33753188
Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients!Q33786003
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of HealthQ34273561
Restless legs syndrome prevalence and impact: REST general population studyQ34426489
Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-AnalysisQ34488657
Restless legs syndrome in patients with irritable bowel syndrome: response to small intestinal bacterial overgrowth therapyQ34583727
Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowthQ34629149
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysisQ34657632
Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort studyQ34745942
Profile of altered brain iron acquisition in restless legs syndromeQ34754646
Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the communityQ34756341
Restless legs syndrome as side effect of second generation antidepressantsQ34777675
Antidepressants for irritable bowel syndromeQ35083805
Epidemiology of restless legs syndrome: a synthesis of the literature.Q35478498
Vitamin D Deficiency in Patients with Irritable Bowel Syndrome: Does it Exist?Q35547840
Prevalence of restless legs syndrome in patients with irritable bowel syndromeQ35555727
Antidepressant medication use and restless legs syndrome in patients presenting with insomniaQ36220871
Risk of Restless Legs Syndrome Following Tension-Type Headache: A Nationwide Population-Based Cohort StudyQ36299351
Elevated C-reactive protein is associated with severe periodic leg movements of sleep in patients with restless legs syndromeQ36309834
Association between irritable bowel syndrome and restless legs syndrome: a comparative study with control groupQ36341718
Increased Risk of Restless Legs Syndrome in Patients With Migraine: A Nationwide Population-Based Cohort StudyQ36566888
Genetic aspects of restless legs syndromeQ36636022
Restless legs syndrome associated with major diseases: A systematic review and new conceptQ36782910
Association between the neutrophil-to-lymphocyte ratio, a new marker of systemic inflammation, and restless legs syndrome.Q37264054
Sex differences in the psychopharmacological treatment of depressionQ37618539
Restless legs syndrome--theoretical roles of inflammatory and immune mechanismsQ37976945
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysisQ37994513
Comorbidities in patients with irritable bowel syndrome with constipation or chronic idiopathic constipation: a review of the literature from the past decadeQ38118478
Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysisQ38202523
The influence of antidepressants on restless legs syndrome and periodic limb movements: A systematic review.Q38617556
British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update).Q38858071
Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndromeQ39150062
Does frequency of restless legs syndrome and poor sleep quality increase with age in irritable bowel syndrome?Q40583195
Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review ArticleQ41392745
Antibiotic therapy may improve idiopathic restless legs syndrome: prospective, open-label pilot study of rifaximin, a nonsystemic antibioticQ43204677
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue8
P921main subjectirritable bowel syndromeQ838966
restless legs syndromeQ916280
population-based cohort studyQ108562148
P304page(s)e0220641
P577publication date2019-08-01
P1433published inPLOS OneQ564954
P1476titleUse of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study
P478volume14

Search more.